<DOC>
	<DOCNO>NCT01633957</DOCNO>
	<brief_summary>Until recently , warfarin still best drug choice long-term anticoagulation patient mechanical prosthetic heart valve . However , complication warfarin account 75 percent whole complication mechanical prosthetic heart valve replacement . Interindividual variation warfarin dose mediate multiple factors.Advanced model use combination clinical attribute genetic factor ( CYP2C9 , VKORC1 , CYP4F2 ) explain 50-75 % variability warfarin dose requirements.These warfarin dose model potential improve patient safety reduce eliminate serious adverse event . The investigator conduct prospective , randomize , blind , two arm trial test hypothesis .</brief_summary>
	<brief_title>A Trial Genotype-based Warfarin Initiation Patients With Mechanical Prosthetic Heart Valve</brief_title>
	<detailed_description />
	<mesh_term>Heart Valve Diseases</mesh_term>
	<mesh_term>Warfarin</mesh_term>
	<criteria>first time receive elective mitral and/or aortic mechanical prosthetic valve replacement willing join clinical trial comply protocol . ethnic group Han previously receive cardiac surgery emergent surgery simultaneously carry cardiac surgery , CABG age young 18y old 65 year drug abuser wine abuser malignancy moderate severe hepatic kidney insufficiency thyroid disease history warfarin VitK consumption 2 week surgery hematological disease history bleed combination drug significantly influence warfarin Cordarone pregnancy contraindication warfarin infectious endocarditis advance valvular disease pathological obesity psychological disease patient join clinical trial previous 30d basic INR &gt; 1.4</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>anticoagulation</keyword>
	<keyword>bleeding</keyword>
	<keyword>CYP2C9</keyword>
	<keyword>CYP4F2</keyword>
	<keyword>VKORC1</keyword>
	<keyword>warfarin dose</keyword>
	<keyword>Heart Valve Diseases</keyword>
	<keyword>pharmacogenomics</keyword>
</DOC>